NCAM1 and bipolar disorder: While we have not identified obvious loss-of-function mutations that would affect the formation of PSA-NCAM in this cohort of patients with bipolar disorder, we have characterised the nucleotide variation that may be associated with the disease, and importantly, in the context of the specific risk and protective haplotypes previously identified.